- FDA Posts Adverse Event Report Data for Animal Drugs and Devices Used in Animals to Increase Transparency
- FDA Approves PROIN ER Tablets for Controlling Urinary Incontinence in Dogs
- FDA Announces Funding Opportunity to Help Define Durations of Use for Certain Medically Important Antimicrobial Drugs for Food Animals
- FDA Issues Revised Question & Answer Draft Guidance on Veterinary Feed Directive Regulation
- Resources for Animal Food Producers in Flooded Central & Southern Plains of U.S.
- FDA Announces New Date for Webinar on Genome Editing in Animals
- Schell returns to FDA to lead Surveillance and Compliance for CVM
- FDA Provides Update on Investigation into Potential Connection Between Certain Diets and Cases of Canine Heart Disease
- FDA Announces Second Approved Insulin for Use in Dogs with Diabetes
- FDA Cautions Pet Owners Not to Feed One Lot of Hare Today Gone Tomorrow Due to Salmonella and Listeria monocytogenes
- FDA Releases Annual Summary Report on Antimicrobials Sold or Distributed in 2017 for Use in Food-Producing Animals Showing Declines for Past Two Years
- FDA Works to Keep Injectable Opioids Available to Treat Animals’ Surgical and Trauma Pain During Ongoing Supply Shortage
- FDA Working with Stakeholders to Maintain Effectiveness of Livestock and Horse Dewormers
- FDA Approves Pexion for Treating Noise Aversion in Dogs
- FDA Alerts Pet Owners about Potentially Toxic Levels of Vitamin D in Several Dry Pet Foods
- FDA Welcomes Grant Applications for Animal Drugs for Minor Uses and Minor Species
- FDA Proposes Study with Intent of Eliminating Use of Dogs in Certain Types of Research
- Registration Reminder: FDA Center for Veterinary Medicine Public Webinar about Genome Editing in Animals on Dec. 3
- FDA Publishes Design Recommendations for Residue Studies in Honey
- FDA Approves Experior for Reduction of Ammonia Gas Released from Beef Cattle Waste
- FDA Announces Plant and Animal Biotechnology Innovation Action Plan
- FDA Warns Two Firms about Monensin Contamination in Horse Feed
- Resources for Animal Food Producers in Flooded Areas of Gulf Coast
- FDA Announces FY 2019 Animal Drug User Fee Rates for ADUFA and AGDUFA
- FDA Announces Availability of Resources for Animal Drug Sponsors
- FDA Animal Drug Safety Communication: FDA Reminds Veterinarians of the Differences Between Approved and Compounded Formulas of Transdermal Mirtazapine for the Management of Weight Loss in Cats
- Animal Drug Safety Communication: FDA Alerts Pet Owners and Veterinarians About Potential for Neurologic Adverse Events Associated with Certain Flea and Tick Products
- FDA Releases Five-Year Plan for Supporting Antimicrobial Stewardship in Veterinary Settings
- Resources for Animal Food Producers in Flooded Areas
- FDA’s Center for Veterinary Medicine Announces Third eSubmitter Webinar in Ongoing Series